NYSE:CLB Core Laboratories (CLB) Stock Price, News & Analysis $9.93 +0.17 (+1.77%) Closing price 10/2/2026 03:59 PM EasternExtended Trading$9.93 -0.01 (-0.08%) As of 10/2/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Core Laboratories Stock (NYSE:CLB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Core Laboratories alerts:Sign Up Key Stats Today's Range$9.74▼$10.1850-Day Range$9.70▼$12.6752-Week Range$9.63▼$20.36Volume623,915 shsAverage Volume572,122 shsMarket Capitalization$455.78 millionP/E Ratio17.74Dividend Yield0.40%Price Target$21.00Consensus RatingHold Company Overview Core Laboratories N.V. (NYSE: CLB) is a global provider of proprietary and patented reservoir description and production enhancement services to the energy industry. Its customers include oil and natural gas exploration and production companies, national oil companies, and independent operators. The company’s reservoir description activities include the analysis of rock and fluid samples, core and special core analysis, petrophysical services, geological and reservoir modeling, and laboratory measurements used to evaluate hydrocarbon reservoirs and improve field development decisions. These services help customers assess reservoir properties, estimate recoverable resources, and plan drilling and production programs. Core Laboratories’ production enhancement business provides services and technologies intended to improve well performance and hydrocarbon recovery. Its offerings include completion and stimulation evaluation, well intervention and production optimization services, and technologies designed for conventional, unconventional, offshore, and enhanced oil recovery projects. The company serves energy markets across North America and international regions through a global network of laboratories, facilities, and field operations.AI Generated. May Contain Errors. Read More Core Laboratories Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks77th Percentile Overall ScoreCLB MarketRank™: Core Laboratories scored higher than 77% of companies evaluated by MarketBeat, and ranked 71st out of 248 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingCore Laboratories has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Upside PotentialCore Laboratories has a consensus price target of $21.00, representing about 111.4% upside from its current price of $9.93.Amount of Analyst CoverageCore Laboratories has only been the subject of 2 research reports in the past 90 days.Read more about Core Laboratories' stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth41.07% Earnings GrowthEarnings for Core Laboratories are expected to grow by 41.07% in the coming year, from $0.56 to $0.79 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Core Laboratories is 17.74, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.66.Price to Earnings Ratio vs. SectorThe P/E ratio of Core Laboratories is 17.74, which means that it is trading at a less expensive P/E ratio than the Energy sector average P/E ratio of about 20.39.Price to Earnings Growth RatioCore Laboratories has a PEG Ratio of 1.98. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCore Laboratories has a P/B Ratio of 1.70. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Core Laboratories' valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.67% of the float of Core Laboratories has been sold short.Short Interest Ratio / Days to CoverCore Laboratories has a short interest ratio ("days to cover") of 10.24, which indicates bearish sentiment.Change versus previous monthShort interest in Core Laboratories has recently increased by 7.01%, indicating that investor sentiment is decreasing significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldCore Laboratories has a dividend yield of 0.41%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCore Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Core Laboratories is 7.14%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Core Laboratories will have a dividend payout ratio of 5.06% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.Read more about Core Laboratories' dividend. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Core Laboratories this week, compared to 2 articles on an average week.Search Interest3 people have searched for CLB on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership3.6 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $53,900.00 in company stock, which represents 0.0118% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Core Laboratories insiders have bought more of their company's stock than they have sold. Specifically, they have bought $53,900.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders1.26% of the stock of Core Laboratories is held by insiders.Percentage Held by Institutions97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Core Laboratories' insider trading history. Receive CLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLB Stock News HeadlinesCORE LABORATORIES ANNOUNCES TIMING OF THIRD QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALLOctober 1 at 4:15 PM | prnewswire.comTop 3 Energy Stocks You'll Regret Missing In SeptemberSeptember 17, 2026 | benzinga.comElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he says is the same size Nvidia was a decade ago. The company holds 150 patents protecting its core technology, and Brown believes Elon Musk could soon drive major demand for it. A key catalyst is set for November 11. | Brownstone Research (Ad)John Rogers Buys Core Laboratories Inc (CLB) -- Shares Look 28% Undervalued on GF ValueAugust 20, 2026 | gurufocus.comThe Top 5 Analyst Questions From Core Laboratories’s Q2 Earnings CallAugust 5, 2026 | msn.comCLB Q2 Deep Dive: Geopolitical Headwinds and Technology Adoption Shape ResultsAugust 4, 2026 | finance.yahoo.comCore Laboratories (CLB) Q2 2026 EarningsJuly 31, 2026 | 247wallst.comCore Laboratories Earnings Call Signals Gradual RecoveryJuly 30, 2026 | tipranks.comSee More Headlines CLB Stock Analysis - Frequently Asked Questions How have CLB shares performed this year? Core Laboratories' stock was trading at $16.02 at the beginning of the year. Since then, CLB stock has decreased by 38.0% and is now trading at $9.9330. How were Core Laboratories' earnings last quarter? Core Laboratories Inc. (NYSE:CLB) issued its earnings results on Wednesday, July, 29th. The oil and gas company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.02. Core Laboratories's revenue was down 4.3% on a year-over-year basis. Read the conference call transcript. How do I buy shares of Core Laboratories? Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Core Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings7/29/2026Record date for 8/31 Dividend8/10/2026Ex-Dividend for 8/31 Dividend8/10/2026Dividend Payable8/31/2026Today10/03/2026Next Earnings (Estimated)10/28/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 CLB's financial health is in the Red zone, according to TradeSmith. CLB has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorEnergy Industry Energy Equipment & Services Sub-IndustryOil & Gas Equipment & Services Current SymbolNYSE:CLB CIK1958086 Webwww.corelab.com Phone(713) 328-2673FaxN/AEmployees3,300Year Founded1936Price Target and Rating Average Price Target for Core Laboratories$21.00 High Price Target$21.00 Low Price Target$21.00 Potential Upside/Downside+111.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)$0.56 Trailing P/E Ratio17.74 Forward P/E Ratio17.74 P/E Growth1.98Net Income$29.67 million Net Margins5.10% Pretax Margin7.09% Return on Equity10.03% Return on Assets4.71% Debt Debt-to-Equity Ratio0.41 Current Ratio2.12 Quick Ratio1.55 Sales & Book Value Annual Sales$519.18 million Price / Sales0.88 Cash Flow$1.07 per share Price / Cash Flow9.29 Book Value$5.85 per share Price / Book1.70Miscellaneous Outstanding Shares45,885,000Free Float45,307,000Market Cap$455.78 million OptionableOptionable Beta1.14 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NYSE:CLB) was last updated on 10/4/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredHow Elon’s Empire Ends (and how to profit)Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredLarry's Three-Step Strategy Revealed at The Dollar Trap SummitLarry unveiled a three-step strategy at last night's Dollar Trap Summit, with no options, futures, or cryptocu...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Laboratories Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Core Laboratories With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
